Idexx Laboratories, Inc (IDXX) may enjoy gains as insiders got busy in the recent days

Daniel Torres

Idexx Laboratories, Inc’s filing revealed that its Executive Vice President Hunt Nimrata unloaded Company’s shares for reported $6.63 million on Nov 07 ’25. In the deal valued at $703.34 per share,9,425 shares were sold. As a result of this transaction, Hunt Nimrata now holds 21,149 shares worth roughly $14.66 million.

Then, NIMRATA K HUNT bought 9,425 shares, generating $6,629,060 in total proceeds.

Before that, SZOSTAK M ANNE sold 2,187 shares. Idexx Laboratories, Inc shares valued at $1,415,700 were divested by the Director at a price of $647.33 per share. As a result of the transaction, SZOSTAK M ANNE now holds 262 shares, worth roughly $0.18 million.

Barclays initiated its Idexx Laboratories, Inc [IDXX] rating to an Overweight in a research note published on December 09, 2025; the price target was $850. A number of analysts have revised their coverage, including Stifel’s analysts, who increased its forecast for the stock in late October from “a Hold” to “a Buy”. UBS began covering IDXX with “Neutral” recommendation on October 01, 2025. BTIG Research maintained its rating on August 05, 2025. It rated IDXX as “a Buy”.

Price Performance Review of IDXX

On Tuesday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock fall -1.05% to $693.18. Over the last five days, the stock has lost -0.84%. Idexx Laboratories, Inc shares have risen nearly 58.56% since the year began. Nevertheless, the stocks have risen 67.66% over the past one year. While a 52-week high of $769.98 was reached on 11/26/25, a 52-week low of $356.14 was recorded on 04/09/25.

Levels Of Support And Resistance For IDXX Stock

The 24-hour chart illustrates a support level at 686.00, which if violated will result in even more drops to 678.83. On the upside, there is a resistance level at 702.03. A further resistance level may holdings at 710.89.

How much short interest is there in Idexx Laboratories, Inc?

A steep rise in short interest was recorded in Idexx Laboratories, Inc stocks on 2025-11-28, growing by 0.51 million shares to a total of 2.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 1.72 million shares. There was a rise of 22.81%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on July 01, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $625 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.